Evidence map›Paper›PMID 19509159›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma.

Hong Jin Lee, Jihyeung Ju, Shiby Paul, Jae-Young So, Andrew DeCastro, Amanda Smolarek, Mao-Jung Lee, Chung S Yang, Harold L Newmark, Nanjoo Suh

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hong Jin LeeDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA.
Jihyeung Ju
Shiby Paul
Jae-Young So
Andrew DeCastro
Amanda Smolarek
Mao-Jung Lee
Chung S Yang
Harold L Newmark
Nanjoo Suh
Rutgers, The State University of New Jersey · USRutgers Cancer Institute of New Jersey

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
Inhibition of breast cancer progression by vitamin D analogs and triterpenoidsR01CA127645 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI SUH, NANJOO · 2008 to 2012
$1.3M
Chemoprevention of cancer by nuclear receptor ligandsR03CA112642 · NCI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI SUH, NANJOO · 2004 to 2005
$156k
NCI NIH HHS NIHR03 CA112642NCI NIH HHS R01 CA127645NCI NIH HHS R01CA127645NCI NIH HHS R03 CA112642NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

purposeTocopherols are lipophilic antioxidants present in vegetable oils. Although the antioxidant and anticancer activities of alpha-tocopherol (vitamin E) have been studied for decades, recent intervention studies with alpha-tocopherol have been negative for protection from cancer in humans. The tocopherols consist of four isoforms, which are the alpha, beta, gamma, and delta variants, and recent attention is being given to other isoforms. In the present study, we investigated the inhibitory effect of a tocopherol mixture rich in gamma- and delta-tocopherols against mammary tumorigenesis. EXPERIMENTAL

designFemale Sprague Dawley rats were treated with N-methyl-N-nitrosourea (NMU), and then fed diets containing 0.1%, 0.3%, or 0.5% mixed tocopherols rich in gamma- and delta-tocopherols for 9 weeks. Tumor burden and multiplicity were determined, and the levels of markers of inflammation, proliferation, and apoptosis were evaluated in the serum and in mammary tumors. The regulation of nuclear receptor signaling by tocopherols was studied in mammary tumors and in breast cancer cells.

resultsDietary administration of 0.1%, 0.3%, or 0.5% mixed tocopherols suppressed mammary tumor growth by 38%, 50%, or 80%, respectively. Tumor multiplicity was also significantly reduced in all three mixed tocopherol groups. Mixed tocopherols increased the expression of p21, p27, caspase-3, and peroxisome proliferator activated receptor-gamma, and inhibited AKT and estrogen signaling in mammary tumors. Our mechanistic study found that gamma- and delta-tocopherols, but not alpha-tocopherol, activated peroxisome proliferator activated receptor-gamma and antagonized estrogen action in breast cancer.

conclusionThe results suggest that gamma- and delta-tocopherols may be effective agents for the prevention of breast cancer.

Indexed as

Alkylating AgentsAnimalsAnticarcinogenic AgentsApoptosisCaspase 3Cell Line, TumorDietary SupplementsFemaleHumansMammary Neoplasms, ExperimentalMethylnitrosoureaPPAR gammaProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyAlkylating AgentsAnticarcinogenic AgentsCaspase 3Methylnitrosoureap27 antigenPPAR gammaProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-aktrho GTP-Binding ProteinsTocopherolsVitamins

Identifiers

PMID19509159
PMCPMC2753525
OpenAlexW2147872600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.